The latest from DTC Perspectives

Call for Presenters for The DTC Perspectives Fall Conference

DTC Perspectives Inc. is currently seeking presenters of ACTIONABLE NEW INSIGHTS for the DTC in the Era of Consumer Choice Conference, October 29-30, 2008 at the Westminster Hotel, Livingston , NJ Submission Deadline Friday, May 30th

CALL FOR PRESENTERS OF ACTIONABLE NEW INSIGHTS -DTC in the Era of Consumer Choice Conference
October 29-30, 2008, Wesminster Hotel , Livingston NJ

DTC Perspectives Inc. is currently seeking presenters of ACTIONABLE NEW INSIGHTS for the DTC in the Era of Consumer Choice Conference, October 29-30, 2008 at the Westminster Hotel, Livingston , NJ . If you have a case study that yields ACTIONABLE NEW INSIGHTS to share with DTC Thought Leaders then we invite you to submit a proposal for a speaking opportunity by close of business Friday, May 30, 2008 . Please submit your proposal by using this link.

Background - DTC in the Era of Consumer Choice Conference,
October 29-30, 2008 Westminster Hotel, Livingston NJ .
The Conference is attended by over 225 industry professionals. Our participants represent all the major pharmaceutical companies, including the key DTC Decision makers, advertising agencies, media outlets, and Internet health companies.

This year's conference is designed to address the crucial and far reaching impact of Consumer Choice in DTC Marketing. The conference aims to provide delegates with pragmatic ideas, learning and insight that will improve both health outcomes and bottom line results. The key themes and issues include:

Consumer Choice and the November 2008 Election Impact on DTC Marketing :

• What will happen in 2009 to pharma consumer marketing if a Democrat wins the White House?
• What are smart marketers anticipating regarding FDA/ DDMAC regulations in this election year?
• What are the most likely new regulation scenarios and how can I best prepare my brand?
• What other measures can we as an industry take to Self-regulate ourselves to pre-empt government involvement?

Consumer Choice and Navigating the Medical, Legal and Regulatory Issues:

• How can pharma marketers join the conversation in social networking - while successfully navigating the medical, legal and regulatory issues? How have companies handled the AE reporting issue? What are the best practices online?
• How can pharma let its guard down a little to allow customers to communicate with us and tell us what they want (esp. 2.0).
• How will review times be impacted by hiring of additional DDMAC staff even as volume of materials submitted to agency continues to increase?  Is there a possibility that Congress reconsiders the 2007 pre-review program (and its fee system) for broadcast DTC and how will this affect marketing plans in 2009?
• Risk Information and the Enlightened Consumer - consumers can Google anything today, plus they are increasingly cynical of pharma coming off the recent issues with Vioxx, and Vytorin, how can marketers best present risk information in this era?
• What are the timelines for DDMAC guidance on online marketing?

Consumer Choice and the Impact on Media Mix:

• Consumers are still heavily connected to network tv stations but much of the interaction is through online or tivo - the issue is not new or old media but the blurring and shifting lines between mediums -
• How can pharma marketers best deal with the changing technology -- DVR's, Digital Cable, TV on Internet, etc?
• What are examples of Pharma brands successfully integrating web 2.0 ( SEM, blogs, social networking, mobile, and widgets) into their marketing mix and what are the key success factors?
• What can we learn from Case studies within and outside our industry on maximizing media plans to dramatically improve ROI?
• How can we maximize targeting, mix, day part, programming, in an era of consumer control?
• Consumer Choice and point of care - there are a seemingly exploding array of new technologies here, Zagat ratings for doctors, drive-through pharmacies - what are the implications for DTC Marketing?
• Who has achieved total Marketing campaign integration and what can we learn from case studies? How can we achieve b etter integration of consumer, healthcare professional, and payor marketing?

Consumer Choice and Brand Engagement

• How can pharma marketers deliver information that is comprehensive and accurate, personally relevant and passionately delivered by credible sources?
• How can pharma brands provide easy to use tools that help consumers translate information in to meaningful action and guide intelligent decision making for patients and caregivers?
• How can marketers enhance access, and provide affordable and convenient opportunities to interact with reputable HC professionals?
• How can Marketers be effective brand champions in an era of User Generated Content and a digital world where consumers are in control?
• What can be learned from the innovation of pharma creating their own programming content?
• Consumer Choice and the Multicultural Opportunity - different people different voices - who had demonstrated success here and what can we learn from examples within and outside of pharma?
• Consumer Choice and the brand loyalty challenge - who has improved compliance and persistence leveraging the empowered consumer and new technologies?

Consumer Choice and New Competitors

• How are generic drugs and the new low priced generic drug programs (eg Walmart) changing the marketing equation for DTC as savvy consumers seek low-price alternatives?
• How can we as an industry rebuild integrity and consumer trust?

Consumer Choice and Improving Health Outcomes and the Bottom Line

• Which brands have embraced Consumer Control to deliver an improved bottom line?
• Who has demonstrated increased ROI in spite of the fragmenting media landscape?
• What actions can pharma marketers take on Monday when they return to the office to immediately improve their bottom line?

We are currently seeking presenters who can share real world examples (successes and failures) implemented by pharma that will help DTC practitioners build their brands, and drive the field of DTC forward in this turbulent environment.

Speaker Submission Requirements for DTC in the Era of Consumer Choice Conference

Submissions must be made through this link and must be received by close of business Friday, May 30,2008 to be considered.

Each submission requires:

• Talk title and 50 word thesis/talk description
• Three key take away's delegates will receive from the talk
• One page biography per speaker
• Pharmaceutical case studies are preferred

Please call Hellen Spanjer, COO DTC Perspectives Inc. with any questions 973-377- 2106 ext 223.

Thank you for your time and consideration,

H.A. Spanjer
COO, DTC Perspectives Inc